• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Eugia Pharma’s Generics Everolimus Receives Approval in US

    FDA

    Eugia’ Generics Nintedanib Receives Tentative Approval in US

    FDA

    Eugia Pharma’s Generics Mesna Receives Approval in US

    FDA

    Eugia Pharma`s Generics Afatinib Receives Approval in US

    FDA

    Eugia Pharma`s Generic Busulfan Receives Approval in US

    FDA

    Eugia`s Generic Sunitinib Malate Receives Approval in the U.S.

    FDA

    Eugia Pharma`s Generic Gentamicin Sulfate Receives Approval in the U.S.

    FDA

    Eugia Pharma`s Generic Sugammadex Receives Approval in the U.S.

    FDA

    Eugia Pharma`s Generic Neostigmine Methylsulfate Receives Approval in the U.S.

    FDA

    Eugia Pharma`s Generic Icatibant Acetate Receives Approval in the U.S.

    FDA

    Eugia Pharma`s Generic Etelcalcetide Receives Approval in the U.S.

    FDA

    Eugia Pharma`s Generic Vancomycin Hydrochloride Receives Approval in the U.S.

    FDA

    Eugia`s Generic Bromfenac Receives Approval in the U.S.

    FDA

    Eugia`s Generic Fulvestrant Receives Approval in the U.S.

    FDA

    Eugia`s Generic (Tobramycin Sulfate) Receives Approval in the U.S.

    FDA

    Eugia`s Generic Bendamustine Hydrochloride Receives Approval in the U.S.

    FDA

    Eugia Pharma`s Generic Bendamustine Hydrochloride Receives Approval in the U.S.

    FDA

    Eugia`s Generic Lenalidomide Receives Approval in the U.S.

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.